TNF and neoplasm: Pathway analyses indicated a difference in immune/inflammatory related signatures between the two primary tumours, such as an enrichment of DEGs in the NF-kappa B signalling and TNF signalling pathways (Supplementary Table 9, Supplementary Fig. 4).